Shanghai Kaibao Pharmaceutical CO.,Ltd (SHE:300039)

China flag China · Delayed Price · Currency is CNY
6.46
+0.06 (0.94%)
At close: Mar 10, 2026
6.25%
Market Cap 6.76B
Revenue (ttm) 1.17B
Net Income (ttm) 345.55M
Shares Out 1.05B
EPS (ttm) 0.33
PE Ratio 19.55
Forward PE n/a
Dividend 0.06 (0.94%)
Ex-Dividend Date Nov 27, 2025
Volume 21,630,510
Average Volume 28,864,215
Open 6.43
Previous Close 6.40
Day's Range 6.42 - 6.49
52-Week Range 5.36 - 7.03
Beta 0.32
RSI 54.74
Earnings Date Apr 22, 2026

About SHE:300039

Shanghai Kaibao Pharmaceutical CO.,Ltd engages in the research, development, production, and sale of modern traditional Chinese medicines primarily in China. The company offers heat-clearing and detoxifying products, such as Tanreqing Injection for wind-heat in the lungs with phlegm-heat obstructing the lungs, early-stage pneumonia, acute bronchitis, acute exacerbations of chronic bronchitis, and respiratory infections; and Phlegm-Heat Clearing Capsules to clear heat, resolve phlegm, and detoxifying. It also provides liver-protecting products, ... [Read more]

Sector Healthcare
Founded 2000
Employees 1,225
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300039
Full Company Profile

Financial Performance

In 2024, SHE:300039's revenue was 1.47 billion, a decrease of -7.57% compared to the previous year's 1.59 billion. Earnings were 375.58 million, an increase of 14.55%.

Financial Statements

News

There is no news available yet.